From our screen of 27 human colorectal cancer cell lines, we found that 14 of them responded to TRAIL, while the remaining 13 malignant cell lines were highly resistant up to a concentration of 250 ng/ml. The gene discussed is TNFSF10; the disease is colorectal cancer.